Cargando…
The role of adjuvant immunomodulatory agents for treatment of severe influenza
A severe inflammatory immune response with hypercytokinemia occurs in patients hospitalized with severe influenza, such as avian influenza A(H5N1), A(H7N9), and seasonal A(H1N1)pdm09 virus infections. The role of immunomodulatory therapy is unclear as there have been limited published data based on...
Autores principales: | Hui, David S., Lee, Nelson, Chan, Paul K., Beigel, John H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801167/ https://www.ncbi.nlm.nih.gov/pubmed/29325970 http://dx.doi.org/10.1016/j.antiviral.2018.01.002 |
Ejemplares similares
-
Adjunctive therapies and immunomodulatory agents in the management of severe influenza
por: Hui, David S., et al.
Publicado: (2013) -
Adjunctive therapies and immunomodulating agents for severe influenza
por: Hui, David S. C., et al.
Publicado: (2013) -
Passive immune therapy and other immunomodulatory agents for the treatment of severe influenza: Systematic review and meta‐analysis
por: Lim, Vanessa W., et al.
Publicado: (2019) -
The use of Ribomunyl(®) in the immunomodulatory treatment of rats with adjuvant arthritis
por: Rovenský, J, et al.
Publicado: (2001) -
Current and future antiviral therapy of severe seasonal and avian influenza
por: Beigel, John, et al.
Publicado: (2008)